| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6004996 | HALEON US HOLDINGS | Tetrahydrolipstatin containing compositions |
Jan, 2018
(6 years ago) | |
Alli is owned by Haleon Us Holdings.
Alli contains Orlistat.
Alli has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Alli are:
- US6004996
Alli was authorised for market use on 07 February, 2007.
Alli is available in capsule;oral dosage forms.
The generics of Alli are possible to be released after 06 January, 2018.
Drugs and Companies using ORLISTAT ingredient
Market Authorisation Date: 07 February, 2007
Treatment: NA
Dosage: CAPSULE;ORAL
How can I launch a generic of ALLI before it's drug patent expiration?
More Information on Dosage
ALLI family patents
